Randomized, double-blind, clinical trial of a polyvalent melanoma vaccine in patients with stage III melanoma.

被引：0
|
作者：
Bystryn, JC
Oratz, R
Shapiro, R
Harris, M
Roses, D
Jacquotte, A
机构：
[1] Kaplan Comprehens Canc Ctr, New York, NY USA
[2] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY USA
[3] NYU, Sch Med, Dept Med, New York, NY USA
[4] NYU, Sch Med, Dept Surg, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1998年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：498 / 498
页数：1
相关论文
共 50 条
  • [1] Randomized, double-blind phase III trial of a polyvalent, shed, melanoma antigen vaccine in stage III melanoma
    Bystryn, JC
    Oratz, R
    Shapiro, RL
    Harris, MN
    Roses, DF
    Jacquotte, A
    Chen, DL
    Rivas, M
    ANNALS OF ONCOLOGY, 1998, 9 : 84 - 84
  • [2] Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine
    Bystryn, JC
    Zeleniuch-Jacquotte, A
    Oratz, R
    Shapiro, RL
    Harris, MN
    Roses, DF
    CLINICAL CANCER RESEARCH, 2001, 7 (07) : 1882 - 1887
  • [3] Randomized, double-blind phase II trial of NY-ESO-1 ISCOMATRIX vaccine and ISCOMATRIX adjuvant alone in patients with resected stage IIc, III, or IV malignant melanoma.
    Cebon, Jonathan S.
    McArthur, Grant A.
    Chen, Weisan
    Davis, Ian D.
    Gore, Martin Eric
    Thompson, John F.
    Millward, Michael
    Findlay, Michael P. N.
    Dunbar, Rod
    Ottensmeier, Christian H. H.
    Venhaus, Ralph Rudolph
    Nathan, Paul D.
    Dalgleish, Angus George
    Cerundolo, Vincenzo
    Maraskovsky, Eugene
    Hopkins, Wendie
    Marsden, Jeremy
    Smithers, B. Mark
    Hersey, Peter
    Evans, T. R. Jeffry
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] A PHASE-III RANDOMIZED, DOUBLE-BLIND, MULTIINSTITUTIONAL TRIAL OF VACCINIA MELANOMA ONCOLYSATE-ACTIVE SPECIFIC IMMUNOTHERAPY FOR PATIENTS WITH STAGE-II MELANOMA
    WALLACK, MK
    SIVANANDHAM, M
    BALCH, CM
    URIST, MM
    BLAND, KI
    MURRAY, D
    ROBINSON, WA
    FLAHERTY, LE
    RICHARDS, JM
    BARTOLUCCI, AA
    ROSEN, L
    CANCER, 1995, 75 (01) : 34 - 42
  • [5] Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: The final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial
    Wallack, MK
    Sivanandham, M
    Balch, CM
    Urist, MM
    Bland, KI
    Murray, D
    Robinson, WA
    Flaherty, L
    Richards, JM
    Bartolucci, AA
    Rosen, L
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 187 (01) : 69 - 77
  • [6] A multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in post-resection melanoma patients at high risk of recurrence
    Slingluff, Craig
    Blumenstein, Brent
    Lewis, Karl
    Andtbacka, Robert
    Hyngstrom, John
    Milhem, Mohammed
    Markovic, Svetomir
    Hamid, Omid
    Hernandez-Aya, Leonel
    Bowles, Tawnya
    Philips, Prejesh
    Claveau, Joel
    Jang, Sekwon
    Lutzky, Jose
    Bar, Anna
    Beitsch, Peter
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [7] Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence
    Slingluff, Craig L.
    Lewis, Karl D.
    Andtbacka, Robert
    Hyngstrom, John
    Milhem, Mohammed
    Markovic, Svetomir N.
    Bowles, Tawnya
    Hamid, Omid
    Hernandez-Aya, Leonel
    Claveau, Joel
    Jang, Sekwon
    Philips, Prejesh
    Holtan, Shernan G.
    Shaheen, Montaser F.
    Curti, Brendan
    Schmidt, William
    Butler, Marcus O.
    Paramo, Juan
    Lutzky, Jose
    Padmanabhan, Arvinda
    Thomas, Sajeve
    Milton, Daniel
    Pecora, Andrew
    Sato, Takami
    Hsueh, Eddy
    Badarinath, Suprith
    Keech, John
    Kalmadi, Sujith
    Kumar, Pallavi
    Weber, Robert
    Levine, Edward
    Berger, Adam
    Bar, Anna
    Beck, J. Thaddeus
    Travers, Jeffrey B.
    Mihalcioiu, Catalin
    Gastman, Brian
    Beitsch, Peter
    Rapisuwon, Suthee
    Glaspy, John
    McCarron, Edward C.
    Gupta, Vinay
    Behl, Deepti
    Blumenstein, Brent
    Peterkin, Joanna J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [8] Final analysis of relapse-free survival in a multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine after resection of high-risk melanoma.
    Slingluff, Craig L.
    Blumenstein, Brent A.
    Lewis, Karl D.
    Andtbacka, Robert Hans Ingemar
    Hyngstrom, John Robert
    Milhem, Mohammed M.
    Markovic, Svetomir
    Hamid, Omid
    Hernandez-Aya, Leonel Fernando
    Bowles, Tawnya Lynn
    Philips, Prejesh
    Jang, Sekwon
    Lutzky, Jose
    Bar, Anna
    Beitsch, Peter D.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: The final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial - Invited commentary
    Wanebo, HJ
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 187 (01) : 77 - 79
  • [10] Phase I/II trial of a PrimeBoost therapeutic vaccine in stage III/IV metastatic melanoma.
    Hawkins, R. E.
    Dangoor, A.
    Keilholz, U.
    Schadendorf, D.
    Harris, A.
    Ottensmeier, C.
    Smyth, J.
    Hoffmnan, K.
    Anderson, R.
    Pearce, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 460S - 460S
12345